These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21570522)

  • 1. Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study.
    Moertl D; Hammer A; Steiner S; Hutuleac R; Vonbank K; Berger R
    Am Heart J; 2011 May; 161(5):915.e1-9. PubMed ID: 21570522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy.
    Nodari S; Triggiani M; Campia U; Manerba A; Milesi G; Cesana BM; Gheorghiade M; Dei Cas L
    J Am Coll Cardiol; 2011 Feb; 57(7):870-9. PubMed ID: 21215550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in male cigarette smokers.
    Din JN; Archer RM; Harding SA; Sarma J; Lyall K; Flapan AD; Newby DE
    Heart; 2013 Feb; 99(3):168-74. PubMed ID: 23184014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of omega-3 polyunsaturated fatty acids on fibrosis, endothelial function and myocardial performance, in ischemic heart failure patients.
    Oikonomou E; Vogiatzi G; Karlis D; Siasos G; Chrysohoou C; Zografos T; Lazaros G; Tsalamandris S; Mourouzis K; Georgiopoulos G; Toutouza M; Tousoulis D
    Clin Nutr; 2019 Jun; 38(3):1188-1197. PubMed ID: 29752009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failure.
    Moertl D; Berger R; Hammer A; Hutuleac R; Koppensteiner R; Kopp CW; Steiner S
    Thromb Haemost; 2011 Sep; 106(3):457-65. PubMed ID: 21800004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
    Udelson JE; McGrew FA; Flores E; Ibrahim H; Katz S; Koshkarian G; O'Brien T; Kronenberg MW; Zimmer C; Orlandi C; Konstam MA
    J Am Coll Cardiol; 2007 Jun; 49(22):2151-9. PubMed ID: 17543634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
    Tavazzi L; Maggioni AP; Marchioli R; Barlera S; Franzosi MG; Latini R; Lucci D; Nicolosi GL; Porcu M; Tognoni G;
    Lancet; 2008 Oct; 372(9645):1223-30. PubMed ID: 18757090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure.
    Morgan DR; Dixon LJ; Hanratty CG; El-Sherbeeny N; Hamilton PB; McGrath LT; Leahey WJ; Johnston GD; McVeigh GE
    Am J Cardiol; 2006 Feb; 97(4):547-51. PubMed ID: 16461054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity.
    Castro PF; Miranda R; Verdejo HE; Greig D; Gabrielli LA; Alcaino H; Chiong M; Bustos C; Garcia L; Mellado R; Vukasovic JL; Godoy I; Lavandero S
    J Heart Lung Transplant; 2008 Apr; 27(4):435-41. PubMed ID: 18374881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial.
    Marchioli R; Levantesi G; Silletta MG; Barlera S; Bernardinangeli M; Carbonieri E; Cosmi F; Franzosi MG; Latini R; Lucci D; Maggioni AP; Moretti L; Nicolosi GL; Porcu M; Rossi MG; Tognoni G; Tavazzi L;
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):735-48. PubMed ID: 19589110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial.
    Aleksova A; Masson S; Maggioni AP; Lucci D; Fabbri G; Beretta L; Mos L; Paino AM; Nicolosi GL; Marchioli R; Tognoni G; Tavazzi L; Sinagra G; Latini R;
    Eur J Heart Fail; 2013 Nov; 15(11):1289-95. PubMed ID: 23839902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Ω-3 fatty acids on endothelial function, arterial wall properties, inflammatory and fibrinolytic status in smokers: a cross over study.
    Siasos G; Tousoulis D; Oikonomou E; Zaromitidou M; Verveniotis A; Plastiras A; Kioufis S; Maniatis K; Miliou A; Siasou Z; Stefanadis C; Papavassiliou AG
    Int J Cardiol; 2013 Jun; 166(2):340-6. PubMed ID: 22100606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function.
    Schiano V; Laurenzano E; Brevetti G; De Maio JI; Lanero S; Scopacasa F; Chiariello M
    Clin Nutr; 2008 Apr; 27(2):241-7. PubMed ID: 18237823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure.
    Tousoulis D; Antoniades C; Vassiliadou C; Toutouza M; Pitsavos C; Tentolouris C; Trikas A; Stefanadis C
    Eur J Heart Fail; 2005 Dec; 7(7):1126-32. PubMed ID: 16051518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals.
    Pot GK; Brouwer IA; Enneman A; Rijkers GT; Kampman E; Geelen A
    Eur J Clin Nutr; 2009 Nov; 63(11):1353-9. PubMed ID: 19623203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.
    Krum H; Ashton E; Reid C; Kalff V; Rogers J; Amarena J; Singh B; Tonkin A
    J Card Fail; 2007 Feb; 13(1):1-7. PubMed ID: 17338996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of short term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failure.
    Gürgün C; Ildizli M; Yavuzgil O; Sin A; Apaydin A; Cinar C; Kültürsay H
    Int J Cardiol; 2008 Jan; 123(2):102-7. PubMed ID: 17320212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence.
    Marchioli R; Silletta MG; Levantesi G; Pioggiarella R; Tognoni G
    Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):110-30. PubMed ID: 20196975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pronounced improvement in systolic and diastolic ventricular long axis function after treatment with metoprolol.
    Grüner Sveälv B; Täng MS; Waagstein F; Andersson B
    Eur J Heart Fail; 2007; 9(6-7):678-83. PubMed ID: 17448723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.